| Prevalence and architecture of de novo mutations in developmental disorders Nature 542 (7642), 433-438, 2017 | 874 | 2017 |
| Large-scale discovery of novel genetic causes of developmental disorders Nature 519 (7542), 223-228, 2015 | 742 | 2015 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 271 | 2019 |
| Histone lysine methylases and demethylases in the landscape of human developmental disorders V Faundes, WG Newman, L Bernardini, N Canham, J Clayton-Smith, ... The American Journal of Human Genetics 102 (1), 175-187, 2018 | 204 | 2018 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 178 | 2019 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 177 | 2018 |
| Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial DI Bernstein, J Guptill, A Naficy, R Nachbagauer, F Berlanda-Scorza, ... The lancet infectious diseases 20 (1), 80-91, 2020 | 129 | 2020 |
| Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART … RAS Salman, DP Minks, D Mitra, MA Rodrigues, P Bhatnagar, ... The Lancet Neurology 18 (7), 643-652, 2019 | 83 | 2019 |
| Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy AH O’Donnell-Luria, LS Pais, V Faundes, JC Wood, A Sveden, V Luria, ... The American Journal of Human Genetics 104 (6), 1210-1222, 2019 | 65 | 2019 |
| Bi-allelic loss-of-function CACNA1B mutations in progressive epilepsy-dyskinesia KM Gorman, E Meyer, D Grozeva, E Spinelli, A McTague, A Sanchis-Juan, ... The American Journal of Human Genetics 104 (5), 948-956, 2019 | 58 | 2019 |
| Harnessing wind is not (by nature) environmentally friendly V Sutton, N Tomich Pace Envtl. L. Rev. 22, 91, 2005 | 44 | 2005 |
| Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke G Mair, R von Kummer, Z Morris, A von Heijne, N Bradey, L Cala, ... Neurology 86 (2), 118-125, 2016 | 43 | 2016 |
| Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... JAMA neurology 78 (10), 1179-1186, 2021 | 35 | 2021 |
| Is There a Doctor (and a Lawyer) in the House? Why Our Good Samaritans Laws Are Doing More Harm than Good for a National Public Health Security Strategy: A Fifty-State Survey V Sutton J. Health & Biomedical l. 6, 261, 2010 | 26 | 2010 |
| A multidisciplinary approach to an ethic of biodefense and bioterrorism V Sutton Journal of Law, Medicine & Ethics 33 (2), 310-322, 2005 | 24 | 2005 |
| A Precarious “Hot Zone”—The President’s Plan to Combat Bioterrorism VV Sutton Bioterrorism: The History of a Crisis in American Society, 283-302, 2020 | 21 | 2020 |
| Law and Bioterrorism: Cases and Materials V Sutton Carolina Academic Press, 2003 | 21 | 2003 |
| Understanding technologies of terror V Sutton, DA Bromley Technology in Society 27 (3), 263-285, 2005 | 20 | 2005 |
| Bioterrorism Preparation and Response Legislation—The Struggle to Protect States' Sovereignty While Preserving National Security V Sutton The Georgetown Public Policy Review, 2001 | 20 | 2001 |
| The George W. Bush Administration and the Environment V Sutton W. New Eng. L. Rev. 25, 221, 2003 | 17 | 2003 |
